[ Price : $8.95]
FDA accepts for priority review a Takeda Pharmaceutical NDA for Eohilia (budesonide oral suspension) for treating eosinophilic eso...[ Price : $8.95]
Two university professors question FDAs decision to assign only one reviewer to several core scientific areas in the Pfizer Covid-...[ Price : $8.95]
An FDA advisory committee votes to recommend an Emergency Use Authorization for Modernas investigational Covid-19 vaccine (mRNA-12...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Controlled Correspondence Related to Generic Drug Developme...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Dry Eye: Developing Drugs for Treatment.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled State Enforcement Notifications 21 CF...[ Price : $8.95]
Federal Register notice: FDA announces the issuance of a priority review voucher to Rhythm Pharmaceuticals related to its rare ped...[ Price : $8.95]
FDA publishes a guidance on how generic drug manufacturers can submit controlled correspondence to FDA seeking generic drug develo...